1)Aberle DR, et al:Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409, 2011
2)Jung KW, et al:Cancer statistics in Korea:incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45:1-14, 2013
3)Ahn HS, et al:Korea's thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med 371:1765-1767, 2014
4)Vaccarella S, et al:Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med 375:614-617, 2016
5)Shinagawa T, et al:The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan:A descriptive study. Int J Cancer 140:618-625, 2017
6)Carter JL, et al:Quantifying and monitoring overdiagnosis in cancer screening:a systematic review of methods. BMJ. 350:g7773
7)Gulati R, et al:Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies. Am J Epidemiol 184:140-147, 2016
8)Independent UK Panel on Breast Cancer Screening:The benefits and harms of breast cancer screening:an independent review. Lancet 380:1778-1786, 2012
9)CANCER RESEARCH UK:Breast cancer screening in the UK http://www.cancerresearchuk.org/about-cancer/type/breast-cancer/about/screening/who-is-screened-for-breast-cancer
10)Ghanouni A, et al:Survey of public definitions of the term ‘overdiagnosis' in the UK. BMJ Open 6:e010723, 2016
11)Esserman LJ1, et al:Addressing overdiagnosis and overtreatment in cancer:a prescription for change. Lancet Oncol 15:e234-242, 2014